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ABSTRACT: Despite the great potential of dried blood spots
(DBS) as a source of endogenous proteins for biomarker
discovery, the literature relating to nontargeted bottom-up
proteomics of DBS is sparse, primarily due to the inherent
complexity and very high dynamic range associated with these
samples. Here, we present proof-of-concept results in which
we have coupled high ﬁeld asymmetric waveform ion mobility
spectrometry (FAIMS) with liquid chromatography−tandem
mass spectrometry (LC−MS/MS) for nontargeted bottom-up
proteomics of DBS with the aim of addressing these
challenges. We, and others, have previously demonstrated the beneﬁts of FAIMS more generally in proteomics including
improved signal-to-noise and extended proteome coverage, and the aim of the current work was to extend those beneﬁts
speciﬁcally to DBS. The DBS samples were either extracted by the more traditional manual “punch and elute” approach or by an
automated liquid surface extraction (LESA) approach prior to trypsin digestion. The resulting samples were analyzed by LC−
MS/MS and LC−FAIMS−MS/MS analysis. The results show that the total number of proteins identiﬁed increased by ∼50% for
the punch and elute samples and ∼45% for the LESA samples in the LC−FAIMS−MS/MS analysis. For both the punch and
elute samples and the LESA samples, ∼30% of the total proteins identiﬁed were observed in both the LC−MS/MS and the LC−
FAIMS−MS/MS data sets, illustrating the complementarity of the approaches. Overall, this work demonstrates the beneﬁts of
inclusion of FAIMS for nontargeted proteomics of DBS.
KEYWORDS: dried blood spots, DBS, high ﬁeld asymmetric waveform ion mobility spectrometry, FAIMS, diﬀerential ion mobility,
proteomics, endogenous proteins
■ INTRODUCTION
Proteomics-based studies are useful in the search for new
biomarkers.1 Blood is a rich source of endogenous proteins and
has great potential for proteomics-based biomarker discovery;2
however, sampling of blood from large patient cohorts can be
both resource-demanding and time-consuming, making the
recruitment of patients into these studies diﬃcult. Dried blood
spots (DBS) are an alternative technique for sampling of blood.
This sampling technique was introduced in 1963 as a means to
sampling and storage of whole blood in newborn screening.3
DBS are easy to obtain and ship, and are well-suited to
sampling from large patient cohorts, including in inaccessible
regions of the world, without the need for transportation of the
patient to the clinic.4,5 Several articles have described the
application of MS for targeted protein analysis of DBS,6−12 but
only two have considered nontargeted protein analysis13−15 by
use of bottom-up proteomics. This is surprising given the wide
body of research on the human plasma proteome16,17 but is
likely the consequence of the complexity of blood samples and
high dynamic range of protein concentrations. These challenges
are not peculiar to proteomics-based studies of DBS or other
blood derived samples and are typically addressed in
proteomics workﬂows through the use of prefractionation
methods such as depletion kits (for removal of high abundance
proteins),18 gel based separation techniques,19 or strong cation
exchange chromatography20 prior to online liquid chromatog-
raphy (LC)−tandem mass spectrometry (MS/MS).
The LC−MS/MS methods used in nontargeted proteomics
are often several hours long, which combined with the need for
sample prefractionation make discovery-based proteomics a
time-consuming process. One approach by which both these
issues may be addressed is the use of gas-phase separation by
ion mobility spectrometry, for example, high ﬁeld asymmetric
waveform ion mobility spectrometry (FAIMS).21 FAIMS has
been shown to be advantageous for bottom-up proteomic
analyses by improving signal-to-noise, extending proteome
coverage and separating isomeric peptides.22−29 FAIMS was
introduced by Buryakov et al.30,31 in 1991 and separates ions on
the basis of their diﬀerential ion mobility in high and low
electric ﬁelds. Ions are passed between two parallel electrodes
to which an asymmetric waveform is applied. As a result of their
diﬀerential ion mobility, the ions will become displaced from
their original trajectory. This displacement can be corrected by
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superposition of a DC voltage (the compensation voltage, CV),
thus allowing the ions to be transmitted through the FAIMS
device. Selective transmission of ions of varying diﬀerential
mobility is achieved by scanning the CV. In addition to the
beneﬁts for bottom-up proteomics, we have recently demon-
strated the advantages oﬀered by FAIMS, when coupled with
liquid extraction surface analysis (LESA), for top-down protein
analysis from thin tissue sections,32,33 bacterial colonies
growing on agar,32 and DBS.34
Here, we have combined bottom-up proteomics of DBS with
FAIMS. Two sample preparation techniques are considered:
the more traditional “punch and elute” method, in which a
small section of the DBS is cut out and the sample eluted into a
solvent prior to tryptic digestion, and an automated surface
extraction and digestion method, utilizing LESA, developed by
Martin et al.13 The samples were then analyzed by LC−MS/
MS and LC−FAIMS−MS/MS. The results show a two-fold
increase in the number of nonredundant proteins detected in
total from both punch and elute prepared samples and LESA
samples.
■ EXPERIMENTAL PROCEDURES
Chemicals
Formic acid (FA), ammonium bicarbonate (ABC), and
acetonitrile (MeCN) were obtained from Sigma-Aldrich (St.
Louis, MO, USA). Trypsin gold Mass Spectrometry grade was
purchased from Promega (Madison, WI, USA).
DBS Samples
The work was approved by the University of Birmingham
STEM Ethical Review Committee (ERN_14−0454). DBS were
acquired from consented healthy human adult donors via ﬁnger
prick onto blood spot (Guthrie) cards, Ahlstrom grade 226
ﬁlter paper from ID Biological Systems (Greenville, USA), and
dried overnight.
Preparation of DBS Samples: “Punch and Elute”
Samples from DBS (n = 2) were cut out (∼5 mm diameter)
and transferred to an Eppendorf vial (Eppendorf, Hamburg,
Germany). Two-hundred microliters of 50 mM ABC buﬀer was
added to the vial, and the sample was extracted on a
Thermomixer from Eppendorf (800 rpm) for 2 h. A volume
of 100 μL of the sample was transferred to a clean vial, and 75
μL of 0.1 μg/mL trypsin was added. The digestion was
performed (vortexing, 500 rpm) at 37 °C overnight (∼18 h).
The samples were pooled and centrifuged at 14 000 rpm for
10 min prior to pipetting the supernatant into 96-well plates
from Thermo Scientiﬁc (Rockford, IL, USA).
Preparation of DBS Samples: Liquid Extraction Surface
Analysis (LESA)
A Triversa Nanomate from Advion Bioscience (New York, NY,
USA) was used for the automatic extraction and digestion of
the DBS samples. A 96-well microtiter plate from Thermo
Scientiﬁc was placed in the Triversa Nanomate and 50 mM
ABC buﬀer was added to one of the wells while 0.1 mg/mL
trypsin solution was added to another well. The DBS samples
were mounted (in total 10 spots) on to the 96-well plate and
surface extraction and digestion of the samples was performed
by using the advanced user interface (AUI) feature of the
ChipSoft software. The procedure was based on the protocol
published by Martin et al.13 Seven microliters of the ABC buﬀer
was aspirated from the well by the robotic pipet, which then
relocated to a deﬁned position over the DBS sample. Six
microliters of the buﬀer was deposited onto the DBS surface
forming a liquid microjunction. The liquid microjunction was
maintained between the tip and the DBS for four seconds
before 5 μL of the buﬀer was reaspirated. The sample was
dispensed into a clean well on the 96-well plate before the tip
was ejected. A new tip was selected and 4.5 μL of trypsin (0.1
mg/mL) was aspirated from the well containing trypsin and
dispensed into the well containing the extracted DBS sample.
The sample was then mixed by one aspiration and dispense
cycle of 4 μL before the tip was ejected. The tryptic digestion
was performed by incubation of the sample for 1 h at 40 °C
using the temperature control unit on the Triversa Nanomate.
To account for the evaporation of solvent during the digest, 7.5
μL of ABC was aspirated from the solvent well and dispensed
into the sample well directly after the digest. In total, 26 surface
extractions from 10 DBS samples were performed (with no
resampling of previously sampled regions). In each case,
individual samples were subjected to proteolysis before pooling
of the resulting digests.
LC−MS
Mass spectrometry experiments were performed on a Thermo
Fisher Orbitrap Elite (Bremen, Germany) equipped with a
Dionex-Ultimate 3000 Nano LC system (Thermo Fisher
Scientiﬁc, Sunnyvale, CA, USA). The peptides were separated
using a C18 150 mm × 0.075 mm id Acclaim Pepmap 100
(pore size 100 Å, particle size 3 μm) from Thermo Scientiﬁc.
All samples were desalted on a C18 5 mm × 0.30 mm id
Acclaim Pepmap 100 (particle size 5 μm) trap column prior to
the HPLC separation. The loading buﬀer, consisting of 0.1%
FA, was ﬂushed through the trap column in the ﬁrst 6 min of
the run. The mobile phase was run with a gradient from 3.2 to
44% MeCN in 30 min. The injection volume was 5 μL and the
column temperature was 35 °C. The peptides were eluted via
the Triversa Nanomate nanospray source (Advion Bioscience,
New York, NY, USA) into the MS with a spray voltage of 1.7
kV. For the FAIMS analysis, the peptides were eluted into the
MS via a nanoESI source equipped with a silica tip emitter (tip
i.d. 10 μm) from New Objective (Woburn, MA, USA) by using
a spray voltage of 3.5 kV. The Orbitrap was operated in the
“top 7” data dependent analysis mode in which a survey scan
(resolving power 120, 000 at m/z 400) was followed by
fragmentation of the seven most abundant precursor ions
within a mass range of m/z 350−1800 or 380−1600 (FAIMS).
The seven most abundant ions were fragmented using collision
induced dissociation (CID) with helium gas and normalized
collision energy of 35%. The fragments were detected in the
linear ion trap. A dynamic exclusion of 60 s was applied to
prevent reselection of the precursor ion.
For the FAIMS analyses, a prototype cylindrical FAIMS
device (electrode gap width of 1.5 mm) supplied by Thermo
Scientiﬁc was mounted on to the Orbitrap.35,36 The temper-
ature of the inner electrode was set to 70 °C, while the outer
electrode was set to 90 °C. The dispersion voltage (DV) was
−5000 V and the CV was swept from −25 to −55 V, in 2.5 V
steps, using the external CV stepping approach as described by
Creese et al.22 Nitrogen was used as the carrier gas.
Data Analysis
Data analysis was performed in Proteome Discoverer 1.4
(Thermo Fisher) using the Sequest algorithm. The MS/MS
data was searched against the SwissProt human database with
20 134 sequences (reviewed and canonical, downloaded March
2017). The following parameters were applied: enzyme was set
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as trypsin; methionine oxidation was set as the variable
modiﬁcation; mass accuracy was set to 10 ppm for parent ion
and 0.6 Da for the fragment ion (product ion type: b and y).
The search also included peptides with up to two missed
cleavages. The data were ﬁltered with a strict false discovery
rate (FDR) of 0.01 and a relaxed FDR of 0.05. The protein
grouping ﬁlter was applied and a minimum of one high
conﬁdent peptide (strict FDR 0.01) was required for a positive
protein.
■ RESULTS AND DISCUSSION
To date, there are two publications describing nontargeted
proteomics of DBS by LC−MS. In the ﬁrst, Chambers et al.
were able to detect 1549 peptides corresponding to 253
proteins using a labor intensive sample preparation method
including 1 h elution of sample from the DBS, overnight tryptic
digest, precipitation, and solid phase extraction.14 In the
second, we demonstrated the detection of 120 proteins from
DBS using a simple and automatic surface extraction (liquid
extraction surface analysis, LESA) followed by automated
digestion of the extracted samples.13
Here, LC−FAIMS−MS is evaluated for the proteomic
analysis of DBS samples using two diﬀerent sample preparation
procedures: (1) punch, elute, and overnight tryptic digest of the
DBS, referred to here as punch and elute, and (2) liquid
extraction surface analysis (LESA) of DBS combined with a 1 h
tryptic digest using the Triversa Nanomate robotic platform
from Advion as described by Martin et al.13 Both sample
preparation procedures were relatively eﬃcient in that no
cleanup of the samples was performed; however, the LESA
procedure was faster than the punch and elute procedure (2 h
elution and ∼18 h digest) as only four seconds surface
extraction and 1 h tryptic digest of the sample was required.
The samples from the punch and elute procedure were
pooled after digestion, as were those from the LESA procedure,
to ensure that any diﬀerences observed were due to the FAIMS
and not diﬀerences in extraction or digestion of the proteins.
Eight replicates of the LC−MS/MS analysis without FAIMS
(described hereafter as without FAIMS) were performed to
evaluate the eﬀect of reanalysis on the total number of peptides
and corresponding proteins identiﬁed. For the samples run with
LC−FAIMS−MS/MS (described hereafter as FAIMS or with
FAIMS), a prototype cylindrical FAIMS device was used.35,36
External CV stepping (i.e., multiple LC−MS/MS analyses each
at constant, and diﬀerent, CV) was chosen rather than the
internal CV stepping (scanning of CV values within one
analytical run) as this has previously been shown to result in
greater numbers of peptide identiﬁcations.22 The CV range was
−55 to −25 V with 2.5 V steps (13 LC−FAIMS−MS/MS
analyses in total) and was chosen based on previous
optimization of CV range for peptides.23,37,38
Numbers of Detected Peptides and Proteins
The average and total number of nonredundant proteins and
peptides detected with and without FAIMS are shown in Table
1. The list of the proteins detected is shown in Supplementary
Table S1 (for punch and elute without FAIMS), Supplementary
Table S2 (for punch and elute with FAIMS), Supplementary
Table S3 (for LESA without FAIMS), and Supplementary
Table S4 (for LESA with FAIMS). All proteomics data,
together with annotated MS/MS spectra for single peptide
protein identiﬁcations, are available via ProteomeXchange with
identiﬁer: PXD007926.
Punch and Elute
For the punch and elute samples, a total of 536 nonredundant
peptides, corresponding to 162 proteins, were identiﬁed in the
analyses without FAIMS (Table 1A). On average, 191 peptides,
corresponding to 68 proteins, were identiﬁed per LC−MS/MS
run. The eﬀect of reanalysis (without FAIMS) of the punch and
elute samples can be seen in Figure S1 in the Supporting
Information. In the ﬁrst run of the punch and elute samples,
260 peptides were detected. The total number of peptides
detected increased to 527 over the next ﬁve LC−MS analyses
of the sample. There was no remarkable increase in the overall
number of peptides detected after six analyses.
For the punch and elute samples analyzed with FAIMS, the
total number of nonredundant peptides was 1065, correspond-
ing to 350 proteins. The average number of peptides identiﬁed
per CV step was 124, corresponding to 80 proteins (Table 1A).
Figure 1A shows the number of detected peptides and proteins
for each CV step. The fewest peptides identiﬁed in a single CV
step was 38 (CV = −55 V), and the greatest number was 210
(CV = −37.5 V). The results show that incorporation of
FAIMS into the workﬂow results in a two-fold increase in the
numbers of peptides and proteins identiﬁed from the punch
and elute samples.
The results obtained for the punch and elute samples with
FAIMS compare favorably (increase of 38% in protein
detection) with those obtained by Chambers et al.14 Chambers
et al. were able to detect 1549 peptides corresponding to 253
proteins from DBS using three replicates. The total instrument
time in those experiments was approximately 5 h, and sample
preparation was labor intensive including SPE and overnight
lyophilization after the overnight tryptic digest. In our
experiments, the total instrument time was 13 h when using
FAIMS with diﬀerent CV steps; however, sample preparation
was minimal. A more reﬁned sample preparation procedure of
the DBS may further increase the number of detected proteins
found when using LC−FAIMS−MS/MS.
LESA
For the LESA samples without FAIMS, a total of 784
nonredundant peptides, corresponding to 187 proteins, were
identiﬁed from eight repeat LC−MS/MS analyses (Table 1B).
The average number of unique peptides detected was 288,
corresponding to 81 proteins. These results are comparable
with those obtained by Martin et al.13 who were able to detect
114 proteins on average (three replicates) by using LESA
extraction of DBS samples followed by tryptic digest and LC−
MS/MS. The increased number of peptides from the LESA
samples (without FAIMS) compared to punch and elute
Table 1. Average Number of Unique Peptides and Proteins
and Total Number of Nonredundant Peptides and Proteins
Detected with and without FAIMS from DBS Using Punch
and Elute Procedure and LESA Procedure
experiment peptidesa proteinsa
nonredundant
peptides
nonredundant
proteins
A: Punch and
Elute
without FAIMS 191 68 536 162
with FAIMS 124 80 1065 350
B: LESA
without FAIMS 288 81 784 187
with FAIMS 119 68 1077 272
aAverage number.
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samples (without FAIMS) was mostly due to an increased
number of peptides from high abundance proteins (e.g., serum
albumin, complement 3 and alpha-2-macroglobulin). As
observed for the punch and elute samples, the total number
of detected peptides increased from 476 in the ﬁrst run to 744
after ﬁve additional LC−MS analyses of the LESA samples
(Supplemental Figure S1B). No signiﬁcant increase was
observed after six runs (as also observed for the punch and
elute sample).
A total of 1077 nonredundant peptides were identiﬁed,
corresponding to 272 proteins, from the LESA samples
analyzed with FAIMS. That corresponds to an increase of
37% in peptide identiﬁcations and 45% in protein identi-
ﬁcations over the LESA samples analyzed without FAIMS. The
average number of peptides identiﬁed per CV step was 119, and
as can be seen in Figure 1B, the fewest peptides were identiﬁed
at CV −25 V (27 peptides) and the greatest number at CV −35
V (214 peptides).
The results obtained for the LESA samples with FAIMS are
an improvement over those obtained by Martin et al.13 without
FAIMS (by over 2-fold) and are comparable with those
obtained by Chambers et al.14 using the punch and elute
extraction method, but with reduced sample preparation
requirements.
Comparison with Plasma Proteomics
It is useful to consider our results with those obtained in plasma
proteomics experiments. For example, Keshishian et al.39
combined immunodepletion of proteins of high- and moderate
abundance with prefractionation of peptide digests (for a total
of 30 peptide fractions) and long liquid chromatography
gradients (3 h analyses) to identify >5000 proteins in human
plasma samples. This result is undoubtedly impressive, but
comes with the caveat that, in addition to the extensive sample
preparation, the total MS analysis time was ∼90 h. More
recently, Mann and co-workers developed a workﬂow for
plasma proteomics in which ∼5 μL of blood is centrifuged and
∼1 μL of plasma harvested.40 The plasma is subsequently
digested with trypsin for 1 h and the resulting peptides analyzed
by LC−MS/MS using a 20 min LC gradient. The total time for
this workﬂow was ∼3 h. The average number of proteins
identiﬁed per individual in the absence of peptide prefractio-
Figure 1. Number of detected proteins (red) and peptides (yellow) for each of the CV steps in the LC−FAIMS−MS/MS analyses of (A) punch and
elute samples and (B) for LESA samples.
Figure 2. Venn diagrams illustrating total nonredundant proteins and peptides identiﬁed when analyzing the samples with FAIMS (all 13 CV steps)
and without FAIMS (eight analysis replicates) for (A) punch and elute samples and (B) LESA extracted samples.
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nation was around 200, rising to ∼300 when a matching library
algorithm was employed. That is, the numbers of proteins
identiﬁed were similar to those identiﬁed in our DBS
experiments when FAIMS was employed.
LESA versus Punch and Elute
The numbers of proteins identiﬁed following LESA and punch
and elute are similar when the DBS samples were analyzed
without FAIMS. The number of identiﬁed proteins was higher
for the punch and elute samples (29% more proteins identiﬁed)
when the samples were analyzed with FAIMS. Further
experiments are required to determine the signiﬁcance of
these observations, but we predict that more proteins are
transferred from the sample and into the buﬀer for the punch
and elute approach (2 h elution) than for the LESA approach
(four seconds surface extraction). In the absence of FAIMS, the
increased number of proteins in the punch and elute samples
will probably be dominated by peptides from the highly
abundant proteins. FAIMS ﬁlters out many peptides from
highly abundant proteins, thus enabling the detection of
peptides in lower concentrations. One example is serum
albumin, which was represented with around 13 unique
peptides in samples run without FAIMS (punch and elute).
In samples run with FAIMS (punch and elute), this protein was
represented with six peptides at CV −32.5 V, and only with one
peptide when using CV −37.5 V. Another example is the
protein complement C3 which was represented by 32 unique
peptides in the analysis without FAIMS (LESA), but with only
seven unique peptides in the analysis with FAIMS (CV −40 V).
Supplementary Table S5 shows some of the highly abundant
proteins and the numbers of unique peptides detected both
from punch and elute samples and LESA samples analyzed with
and without FAIMS. The table shows that more peptides from
high abundance proteins were detected from samples analyzed
without FAIMS and may explain the increased overall number
of proteins identiﬁed in samples analyzed with FAIMS.
Complementarity of Analyses with and without FAIMS
The complementarity of the results obtained following analyses
performed with and without FAIMS is illustrated in Figure 2.
Figure 2A shows Venn diagrams of the total number of
nonredundant peptides and proteins identiﬁed from the punch
and elute samples analyzed with and without FAIMS. The total
number of proteins identiﬁed by both approaches was 392, with
59% unique to FAIMS, 11% unique to non-FAIMS, and 30%
(120 proteins) observed in both. The total number of peptides
identiﬁed was 1270, with 58% unique to FAIMS, 16% unique to
non-FAIMS, and 26% (331 peptides) common to both. A
similar trend was observed for the LESA samples (Figure 2B).
A total of 350 proteins were identiﬁed, with 47% unique to
FAIMS, 22% unique to non-FAIMS, and 31% (109 proteins)
observed in both. For peptides the total number was 1406, with
44% unique to FAIMS, 23% unique to non-FAIMS, and 32%
(455 peptides) seen in both. These results are in agreement
with earlier work demonstrating the complementarity of LC−
MS/MS workﬂows incorporating FAIMS and without FAIMS
in terms of peptide and protein identiﬁcation.22,23
Redundancy between CV Steps
Figure 3A shows a Venn diagram of proteins identiﬁed in the
punch and elute samples analyzed at CV steps −25, −37.5, and
−55 V. Approximately 60% (33 proteins) of proteins identiﬁed
at CV = −25 V were not identiﬁed when the same sample was
run with CV = −37.5 V, and around 50% (15 proteins) of the
proteins identiﬁed at CV = −55 V were not found when using
CV = −37.5 V. The number of proteins identiﬁed in all three
analyses was eight, corresponding to less than 5% of the total.
Figure 3B shows a Venn diagram of proteins found in three
LC−MS/MS analyses performed in the absence of FAIMS.
49% of the peptides identiﬁed in these analyses were observed
in all three runs, and 68% were identiﬁed in two or more
analyses. A similar analysis was performed for the LESA
samples, see Supporting Information Figure S2. For the FAIMS
analyses, 7% of the total proteins identiﬁed were observed at all
three CV steps (CV = −25, −37.5, and −55 V). For the non-
FAIMS analyses, 53% of proteins were identiﬁed in all three
analyses and 65% were identiﬁed in two or more analyses. Total
ion chromatograms from samples run with FAIMS (CV = −25,
−37.5 and −55 V) and without FAIMS are shown in Figure S3
(punch and elute samples) and Figure S4 (LESA samples) in
the Supporting Information. These chromatograms further
conﬁrm that diﬀerent information is acquired with and without
FAIMS.
Figure 3. Redundancies of proteins found when analyzing the punch and elute samples with (A) FAIMS using three diﬀerent CV steps and (B) three
analysis replicates without FAIMS.
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Charge State Distributions
The charge states of the peptides detected for samples analyzed
with and without FAIMS were evaluated and can be seen in
Figure S5 in the Supporting Information. Without FAIMS, the
percentage of peptides with charge states ≥ +3 charges were
fairly constant at ∼30% from run to run. When the samples
were analyzed with FAIMS, an increase in the percentage of
peptides with charge states ≥ +3 was observed as the CV
voltage was lowered (more negative). The same trend was also
observed for the punch and elute samples (data not shown).
This distribution of peptide m/z with varying CV has been
described previously.23,38
Detection of Lower Abundance Proteins
Table 2 shows examples of proteins of lower abundance (as
described by Hortin et al.41 and Liu et al.42) that were identiﬁed
from the DBS samples and the typical plasma concentration of
these proteins. As discussed above, many high abundance
proteins were detected in samples analyzed both without
FAIMS and with FAIMS; however, fewer signature peptides
from high abundance proteins were seen with FAIMS. Proteins
that are at the lower concentration range of the typical high
abundance proteins (<100 μg/mL) were also detected:
apolipoprotein L1, protein S100-A8 and A9. Proteins with
plasma concentrations less than 100 ng/mL were also detected:
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), car-
bonic anhydrase 2, vinculin, beta-parvin, and prothrombin.
For the punch and elute samples, only GAPDH and carbonic
anhydrase 2 were observed in the non-FAIMS analyses, and all
but S100 A8 were observed in the FAIMS analyses. For the
LESA samples, S100 A9, GAPDH, and carbonic anhydrase
were observed without FAIMS, and all but beta-parvin were
observed with FAIMS.
Although S100 A8, apolipoprotein L1, and prothrombin were
only observed here with FAIMS analysis, it should be noted
that both were observed previously by Martin et al.13 (LESA,
no FAIMS) and Chambers et al.14 (punch and elute, no
FAIMS). Similarly, S100 A9 was not observed here in the
punch and elute samples with FAIMS but was seen previously
by Chambers et al. Glyceraldehyde-3-phosphate dehydrogenase
and carbonic anhydrase 2 were seen both without and with
FAIMS and were also observed by both Chambers et al. and
Martin et al. Vinculin and beta-parvin were not detected in the
samples from either Chambers et al. or Martin et al.
■ CONCLUSIONS
Here, we have evaluated FAIMS coupled with LC−MS/MS for
nontargeted proteomics of DBS and have considered two DBS
sample preparation methods, the well-established punch and
elute approach and the more recent LESA approach. These
proof-of-concept results show that for both sample preparation
approaches, the inclusion of FAIMS in the LC−MS/MS
workﬂow results in an approximately two-fold increase in the
number of proteins identiﬁed. Our ﬁndings also show the
complementarity of data sets obtained with and without
FAIMS. Between one-quarter and one-third of the total
proteins identiﬁed were common to both FAIMS and non-
FAIMS data sets, with over 40% unique to FAIMS. Overall, our
results suggest that FAIMS may have a role to play in DBS
proteomics by addressing the challenges of sample complexity
and dynamic range.
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protein S100 A8 05−1.5b no no no −35, −37.5
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